Stocks edge lower as Wall Street's momentum slows down


Street signs at the intersection of Wall and Broad Streets are shown in lower Manhattan, Wednesday, Oct. 13, 2021. Stocks are opening lower on Wall Street Monday, Oct. 18, 2021, as the market's momentum slows following its best week since July. (AP Photo/John Minchillo, File)

Stocks edged lower in morning trading on Wall Street Monday as the market’s momentum slows following its best week since July.

The S&P 500 fell 0.1% as of 10:15 a.m. Eastern. The Dow Jones Industrial Average fell 131 points, or 0.4%, to 35,163 and the Nasdaq rose 0.1%.

Technology and health care stocks were the biggest weights on the benchmark S&P 500. Medical device company Medtronic fell 4.6% and data storage company NetApp fell 3.5%.

Energy stocks gained ground as U.S. crude oil prices rose 0.8%. Prices have soared 70% so far this year. Occidental Petroleum rose 6.7%. A mix of retailers and other companies that rely on consumer spending also rose.

The yield on the 10-year Treasury rose to 1.59% from 1.57% late Friday.

The broader market has been choppy for weeks as investors try to figure out the economy's path ahead as COVID-19 remains a lingering threat, while businesses and consumers face rising inflation. The S&P 500 rose 1.8% last week for its best week since July, though it shed 2.2% just two weeks prior.

Investors are busy reviewing the latest round of corporate earnings for a better picture of how companies fared through the surge of virus cases last quarter and how many are dealing with rising inflation's impact on costs.

Health care giant Johnson & Johnson will report its latest results on Tuesday, as will streaming entertainment service Netflix. Investors will get a better sense of how airlines are recovering when several major carriers report results this week. United Airlines will report its latest results on Tuesday, with American Airlines and Southwest Airlines reporting their results on Thursday.

Investors also have several pieces of economic data to review this week. The Federal Reserve on Monday reported a surprisingly big drop in industrial production. Nearly half of the 1.3% drop was caused by the lingering effects of Hurricane Ida.


Wall Street will also get more information on the housing market's health this week with the Commerce Department's report on housing starts for September on Tuesday and the National Association of Realtors' report on sales of previously occupied homes in September on Thursday.

Should you invest $1,000 in United Airlines right now?

Before you consider United Airlines, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and United Airlines wasn't on the list.

While United Airlines currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Johnson & Johnson (JNJ)
4.908 of 5 stars
$146.82-1.2%3.24%9.15Hold$175.86
Medtronic (MDT)
4.6721 of 5 stars
$79.25-1.4%3.48%25.24Hold$94.91
United Airlines (UAL)
4.6158 of 5 stars
$53.51+1.6%N/A6.61Moderate Buy$66.53
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

JNJ shares hit a low, trading near $145 at under 14X earnings. With a high dividend yield, it's poised for a rebound.

Search Headlines: